REG - e-Therapeutics plc - Total Voting Rights

E-TherapeuticsAnnouncement

30/07/2021 07:00

RNS Number : 6411G
  
e-Therapeutics plc
  
30 July 2021
  
 

30 July 2021
e-therapeutics plc
Total Voting Rights
 
e-therapeutics plc (AIM: ETX.L, "e-therapeutics'" or "the Company"), announces that in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company has 514,553,598 ordinary shares of 0.1 pence each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 514,553,598.
The above figure of 514,553,598 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.
Enquiries:



e-therapeutics plc








Ali Mortazavi, CEO
Karl Keegan, CFO
 


Tel: +44 (0)1993 883 125 www.etherapeutics.co.uk














SP Angel Corporate Finance LLP


Tel: +44(0)20 3470 0470 




Nominated Adviser and Broker








Matthew Johnson/Caroline Rowe (Corporate Finance)








Vadim Alexandre/Rob Rees (Corporate Broking)







 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
TVRMZGZNZNVGMZM